v3.26.1
Stockholder's Equity - Schedule of unvested shares of restricted stock (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Jan. 31, 2025
shares
Jan. 31, 2025
Mar. 31, 2026
installment
$ / shares
shares
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
shares
Equity instrument activity            
Outstanding, at beginning of period (in shares)     2,508,721      
Granted (in shares)     533,094      
Earned at completion of three-year performance period (in shares)     12,052      
Conversion to common stock (in shares)     (5,413)      
Vesting of restricted shares (in shares)     (133,666)      
Outstanding, at end of period (in shares)     2,914,788      
Weighted Average Grant Date Fair Value            
Weighted average grant date fair value at beginning of period (in dollars per share) | $ / shares     $ 15.07      
Granted (in dollars per share) | $ / shares     18.68      
Earned at completion of three-year performance period (in dollars per share) | $ / shares     19.35      
Conversions to common stock (in dollars per share) | $ / shares     15.06      
Vesting of restricted shares (in dollars per share) | $ / shares     15.75      
Weighted average grant date fair value at end of period (in dollars per share) | $ / shares     $ 15.72      
Performance period   3 years   3 years 3 years  
CEO | LTIP | Operating Partnership Unitholders’ Non-controlling Interests            
Weighted Average Grant Date Fair Value            
Shares issued in period (in shares)     184,877      
President | LTIP | Operating Partnership Unitholders’ Non-controlling Interests            
Weighted Average Grant Date Fair Value            
Shares issued in period (in shares)     91,287      
Certain Employees | LTIP | Operating Partnership Unitholders’ Non-controlling Interests            
Weighted Average Grant Date Fair Value            
Shares issued in period (in shares) 92,891          
Officers and employees            
Weighted Average Grant Date Fair Value            
Restricted stock withholdings (in shares)     81,009      
Restricted shares withheld (in shares)     52,657      
Restricted Shares            
Equity instrument activity            
Outstanding, at beginning of period (in shares)     477,452      
Granted (in shares)     81,674      
Earned at completion of three-year performance period (in shares)     0      
Conversion to common stock (in shares)     0      
Vesting of restricted shares (in shares)     (62,797)      
Outstanding, at end of period (in shares)     496,329      
Restricted Shares | Officers and employees            
Weighted Average Grant Date Fair Value            
Number of award vesting installments | installment     3      
Restricted Shares | Officers and employees | Share-Based Payment Arrangement, Tranche One            
Weighted Average Grant Date Fair Value            
Award vesting period     3 years      
Restricted Shares | Officers and employees | Share-Based Payment Arrangement, Tranche Two            
Weighted Average Grant Date Fair Value            
Award vesting period     5 years      
Restricted Shares | Officers and employees | Share-Based Payment Arrangement, Tranche Three            
Weighted Average Grant Date Fair Value            
Award vesting period     8 years      
LTIP Units            
Equity instrument activity            
Outstanding, at beginning of period (in shares)     1,669,217      
Granted (in shares)     369,055      
Earned at completion of three-year performance period (in shares)     0      
Conversion to common stock (in shares)     (5,413)      
Vesting of restricted shares (in shares)     0      
Outstanding, at end of period (in shares)     2,032,859      
RSUs            
Equity instrument activity            
Outstanding, at beginning of period (in shares)     362,052      
Granted (in shares)     82,365     47,005
Earned at completion of three-year performance period (in shares)     12,052      
Conversion to common stock (in shares)     0      
Vesting of restricted shares (in shares)     (70,869)      
Outstanding, at end of period (in shares)     385,600      
RSUs | Certain Officers and Employees            
Equity instrument activity            
Granted (in shares)     71,041      
Market-Based RSUs            
Weighted Average Grant Date Fair Value            
Requisite service period     3 years      
Time-Based RSUs | Certain Employees            
Equity instrument activity            
Granted (in shares)     11,325      
Performance-Based RSUs            
Weighted Average Grant Date Fair Value            
Performance period         3 years  
Performance target earned, percentage     123.10%